KALY Confirms Pharmaceutical Cannabis Extract Report On Recent Trials Scheduled For Tomorrow
March 21 2019 - 12:33PM
InvestorsHub NewsWire
KALY Confirms Pharmaceutical
Cannabis Extract Report On Recent Trials Scheduled For
Tomorrow
Dallas, TX -- March 21, 2019 --
InvestorsHub NewsWire -- Kali-Extracts, Inc. (Kali, Inc.
dba/Kali-Extracts, Inc.) (USOTC:
KALY) (“KALY”) today confirmed the company plans to publish its
phase one research on the pilot treatment
of Chronic Obstructive Pulmonary Disease (COPD) in
primates. The primate study adds to the Kali-Extracts in
vitro genomics study, previously announced, to evaluate the impact
of its pharmaceutical grade cannabis extracts in combination with
other therapies on COPD
patients.
KALY is a health and wellness company set to
generate revenue from its patented cannabis extraction technology
through overlapping go-to-market strategies. In addition
developing pharmaceutical products internally and through
partnerships, KALY is utilizing is patented cannabis extraction
process to develop numerous wellness products both internally and
through partnerships.
To learn more
about the company visit https://www.kali-extracts.com/
This press
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), and as such, may involve risks and uncertainties.
These forward looking statements relate to, amongst other things,
current expectation of the business environment in which the
company operates, potential future performance, projections of
future performance and the perceived opportunities in the market.
The company's actual performance, results and achievements may
differ materially from the expressed or implied in such
forward-looking statements as a result of a wide range of
factors.
CONTACT:
Frederick Ferri
ir@kali-extracts.com
(214)
210-0459
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2023 to Sep 2024